Anti-CIART Polyclonal Antibody from ProteoGenix; catalogue ARO-A22017; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-CIART Polyclonal Antibody: A Powerful Tool for Detecting CIART Protein in Biotech Research
The Anti-CIART Polyclonal Antibody is a highly specific and sensitive tool designed for the detection of CIART protein in biotech research. This antibody is produced using advanced recombinant technology and has been extensively validated for its performance and reliability.
CIART (Cytokine-Induced Apoptosis-Related Protein 1) is a key protein involved in the regulation of cell death and survival pathways. It is known to be induced by cytokines and plays a crucial role in various cellular processes, including apoptosis, inflammation, and immune response. Dysregulation of CIART has been linked to various diseases, making it an important target for biotech research.
The Anti-CIART Polyclonal Antibody is specifically designed for the detection of CIART protein in various biological samples. It is suitable for use in Western blotting, immunohistochemistry, and immunofluorescence applications. This antibody has been validated for use in both human and animal samples, making it a versatile tool for a wide range of research projects.
The Anti-CIART Polyclonal Antibody has been successfully used in various research studies, including cancer research, inflammation studies, and immune response studies. In cancer research, this antibody has been used to detect CIART expression in tumor tissues and to study its role in tumor progression and metastasis. In inflammation studies, it has been used to investigate the involvement of CIART in inflammatory pathways. Additionally, in immune response studies, this antibody has been used to detect CIART expression in immune cells and to study its role in regulating immune response.
In conclusion, the Anti-CIART Polyclonal Antibody is a highly specific and sensitive tool for detecting CIART protein in biotech research. Its advanced technology, extensive validation, and versatility make it an essential tool for any researcher studying CIART and its role in various biological processes. Order now and take your biotech research to the next level.
ProteoGenix catalogue number ARO-A22017. For research use only.
Target: CIART; Clonality: Polyclonal Antibody; Applications: IHC, ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| CIART |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
